Logo image
Mapping the redox state of CHOP-treated non-Hodgkin's lymphoma xenografts in mice
Journal article   Peer reviewed

Mapping the redox state of CHOP-treated non-Hodgkin's lymphoma xenografts in mice

He N Xu, Tahreem A Mir, Seung-Cheol Lee, Min Feng, Namisa Farhad, Regine Choe, Jerry D Glickson and Lin Z Li
Advances in experimental medicine and biology, Vol.789, pp.243-249
2013
DOI: 10.1007/978-1-4614-7411-1_33
PMCID: PMC4526262
PMID: 23852501
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4526262View
Open Access

Abstract

Drug treatment may alter the metabolism of cancer cells and may alter the mitochondrial redox state. Using the redox scanner that collects the fluorescence signals from both the oxidized flavoproteins (Fp) and the reduced form of nicotinamide adenine dinucleotide (NADH) in snap-frozen tumor tissues, we investigated the effects of chemotherapy on mouse xenografts of a human diffuse large B-cell lymphoma cell line (DLCL2). The mice in the treatment group were treated with CHOP - cyclophosphamide (C) + hydroxydoxorubicin (H) + Oncovin (O) + prednisone (P) using the following regimen: CHO administration on day 1 followed by prednisone administration on day 1-5. On day 5 the mitochondrial redox state of the treated group was slightly more reduced than that of the control group (p = 0.049), and the Fp content of the treated group was significantly decreased (p = 0.033).
Animals Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - pharmacology Cell Line, Tumor Cyclophosphamide - administration & dosage Doxorubicin - administration & dosage Female Humans Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - metabolism Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - metabolism Mice Mice, Nude Mitochondria - drug effects Mitochondria - metabolism NAD - metabolism Oxidation-Reduction Prednisone - administration & dosage Vincristine - administration & dosage Xenograft Model Antitumor Assays

Details

Metrics

Logo image